Fifth disease - Morbus Quintus
☆ AI Dermatology — Free Service
In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
XVI MENSTRUALIS Morbus Quintus (Fifth disease) Utraeque genae rubescunt, quasi alapae, et epinyctides maculopapulares in corpore apparent.
Utrumque genus Erythema.
relevance score : -100.0%
ReferencesFifth disease, etiam notum erythema infectiosum, est infectio viralis a parvovirus B19 causata. Praesertim in pueris, afficit eos inter 4 et 14 annos. Signa saepe incipiunt cum levia febre, cefalalgia, pharyngite et affectionibus cutaneis. In pueris rubor distinctus in facie, similis “slapped cheeks”, cum maculis in corpore, brachiis et cruribus. In adultis dolor articularis frequens est, qui paucas septimanas post infectionem initialem apparere potest. Notabile, circa 20‑30 % adultorum infectorum parvovirus B19 nullas signa exhibere possunt.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Periculum transmissionis parvovirus B19 a matre ad infantem est circa 33 %, cum circa 3 % mulierum infectarum difficultates in infantibus experiatur. Cum mater ante XX septimanas graviditatis infecta est, possunt ori ri complicationes, ut problemata sanguinis et fluidorum in incremento corporis infantis. Inquisitionem huius morbi incipere oportet, si aeger parvovirus B19 expositus est, per analysim elementorum (IgM). Si probatio nullam praeteritam expositionem sed recentem contagionem indicat, aeger requirit magnam vigilantiam in graviditate, inter quae sunt ultrasounds scans ad reprimendam quaestiones sanitatis infantis.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
Morbus Quintus (Fifth disease) incipit a humilibus symptomatibus febris, capitis, praecipitis, et frigoris simile, sicut nasus liquescit vel odoratus. Post paucis diebus, rash apparens. Rubor maculatus maxime apparet in facie, praesertim in genis (unde nomen "morbus maxillam obduxit"). Praeter genas rubentes, pueri saepe rubram, lacyam in reliquo corpore manifestant, in brachiis, abdomine, cruribusque locis frequentissimis.
Morbus lenis esse solet, sed in praegnantibus infectio in primo trimestre potest ducere ad hydrops fetalis, abortum spontaneum causans.
○ Curatio
Nulla specifica curatio requiritur; plerumque morbus se meliorat tempore.